The CB Receptor and Its Role As a Regulator of Inflammation

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2016 Jul 13

PMID 27402121

Citations 235

Authors

Caroline Turcotte

Marie-Renee Blanchet

Michel Laviolette

Nicolas Flamand

Affiliations

Soon will be listed here.

Abstract

The CB receptor is the peripheral receptor for cannabinoids. It is mainly expressed in immune tissues, highlighting the possibility that the endocannabinoid system has an immunomodulatory role. In this respect, the CB receptor was shown to modulate immune cell functions, both in cellulo and in animal models of inflammatory diseases. In this regard, numerous studies have reported that mice lacking the CB receptor have an exacerbated inflammatory phenotype. This suggests that therapeutic strategies aiming at modulating CB signaling could be promising for the treatment of various inflammatory conditions. Herein, we review the pharmacology of the CB receptor, its expression pattern, and the signaling pathways induced by its activation. We next examine the regulation of immune cell functions by the CB receptor and the evidence obtained from primary human cells, immortalized cell lines, and animal models of inflammation. Finally, we discuss the possible therapies targeting the CB receptor and the questions that remain to be addressed to determine whether this receptor could be a potential target to treat inflammatory disease.

Citing Articles

CANDI: a web server for predicting molecular targets and pathways of cannabis-based therapeutics.

Ekambaram S, Wang J, Dokholyan N J Cannabis Res. 2025; 7(1):13.

PMID: 40016810 PMC: 11866588. DOI: 10.1186/s42238-025-00268-w.

Cannabinoid-2 Receptor Activation Attenuates Sulfur Mustard Analog 2-Chloroethyl-Ethyl-Sulfide-Induced Acute Lung Injury in Mice.

Nicholson G, Richards N, Lockett J, Ly M, Nair R, Kim W Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006049 PMC: 11860106. DOI: 10.3390/ph18020236.

New Insights in Natural Bioactive Compounds for Periodontal Disease: Advanced Molecular Mechanisms and Therapeutic Potential.

Hashim N, Babiker R, Chaitanya N, Mohammed R, Priya S, Padmanabhan V Molecules. 2025; 30(4).

PMID: 40005119 PMC: 11858609. DOI: 10.3390/molecules30040807.

Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials.

Hakami A, Alshehri F Front Pharmacol. 2025; 16:1521792.

PMID: 39981181 PMC: 11839665. DOI: 10.3389/fphar.2025.1521792.

Cannabinoid receptor 2 selective agonist ameliorates adjuvant-induced arthritis by modulating the balance between Treg and Th17 cells.

Tian N, Yang C, Du Y, Chen M, Li B, Li D Front Pharmacol. 2025; 16:1532518.

PMID: 39959429 PMC: 11825454. DOI: 10.3389/fphar.2025.1532518.

References

Batkai S, Mukhopadhyay P, Horvath B, Rajesh M, Gao R, Mahadevan A . Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors. Br J Pharmacol. 2011; 165(8):2450-61. PMC: 3423240. DOI: 10.1111/j.1476-5381.2011.01410.x. View

Signorello M, Giacobbe E, Passalacqua M, Leoncini G . The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets. Biochimie. 2013; 95(8):1620-8. DOI: 10.1016/j.biochi.2013.05.003. View

He F, Qiao Z, Cai J, Pierce W, He D, Song Z . Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. Mol Pharmacol. 2007; 72(5):1289-300. DOI: 10.1124/mol.107.036566. View

Hanus L, Fride E, Breuer A, Vogel Z, Shalev D, Kustanovich I . 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci U S A. 2001; 98(7):3662-5. PMC: 31108. DOI: 10.1073/pnas.061029898. View

Zhou L, Lin Z, Fung K, Cheng C, Che C, Zhao M . Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-κB activity. Eur J Pharmacol. 2011; 670(2-3):399-408. DOI: 10.1016/j.ejphar.2011.09.014. View

Rayman N, Lam K, Laman J, Simons P, Lowenberg B, Sonneveld P . Distinct expression profiles of the peripheral cannabinoid receptor in lymphoid tissues depending on receptor activation status. J Immunol. 2004; 172(4):2111-7. DOI: 10.4049/jimmunol.172.4.2111. View

Sardinha J, Kelly M, Zhou J, Lehmann C . Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis. Mediators Inflamm. 2014; 2014:978678. PMC: 3997158. DOI: 10.1155/2014/978678. View

Amenta P, Jallo J, Tuma R, Elliott M . A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. J Neurosci Res. 2012; 90(12):2293-305. DOI: 10.1002/jnr.23114. View

Murikinati S, Juttler E, Keinert T, Ridder D, Muhammad S, Waibler Z . Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J. 2009; 24(3):788-98. DOI: 10.1096/fj.09-141275. View

10.

Gkoumassi E, Dekkers B, Droge M, Elzinga C, Schmidt M, Meurs H . Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells. Br J Pharmacol. 2007; 151(7):1041-8. PMC: 2042924. DOI: 10.1038/sj.bjp.0707320. View

11.

El-Talatini M, Taylor A, Elson J, Brown L, Davidson A, Konje J . Localisation and function of the endocannabinoid system in the human ovary. PLoS One. 2009; 4(2):e4579. PMC: 2640464. DOI: 10.1371/journal.pone.0004579. View

12.

Ashton J, Friberg D, Darlington C, Smith P . Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett. 2005; 396(2):113-6. DOI: 10.1016/j.neulet.2005.11.038. View

13.

Comelli F, Giagnoni G, Bettoni I, Colleoni M, Costa B . The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation. Br J Pharmacol. 2007; 152(5):787-94. PMC: 2190015. DOI: 10.1038/sj.bjp.0707425. View

14.

Maresz K, Pryce G, Ponomarev E, Marsicano G, Croxford J, Shriver L . Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med. 2007; 13(4):492-7. DOI: 10.1038/nm1561. View

15.

Wang H, Dey S, Maccarrone M . Jekyll and hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev. 2006; 27(5):427-48. DOI: 10.1210/er.2006-0006. View

16.

Kishimoto S, Oka S, Gokoh M, Sugiura T . Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. Int Arch Allergy Immunol. 2006; 140 Suppl 1:3-7. DOI: 10.1159/000092704. View

17.

Engel M, Kellermann C, Burnat G, Hahn E, Rau T, Konturek P . Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis. J Physiol Pharmacol. 2010; 61(1):89-97. View

18.

Ibrahim M, Deng H, Zvonok A, Cockayne D, Kwan J, Mata H . Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A. 2003; 100(18):10529-33. PMC: 193595. DOI: 10.1073/pnas.1834309100. View

19.

Chiurchiu V, Lanuti M, Catanzaro G, Fezza F, Rapino C, Maccarrone M . Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. Atherosclerosis. 2014; 233(1):55-63. DOI: 10.1016/j.atherosclerosis.2013.12.042. View

20.

Zoratti C, Kipmen-Korgun D, Osibow K, Malli R, Graier W . Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. Br J Pharmacol. 2003; 140(8):1351-62. PMC: 1574152. DOI: 10.1038/sj.bjp.0705529. View